The wearable technology market is entering an interesting new phase. For years, smartwatches, fitness bands, and smart rings were mostly viewed as consumer gadgets. They counted steps, measured heart rate, tracked workouts, and gave people another stream of numbers to look at on their phones.
That is changing.
Oura and Whoop are increasingly being positioned as something much bigger: health platforms built around recurring subscriptions, personal data, and increasingly sophisticated artificial intelligence.
That combination is exactly why their potential public-market debuts are attracting so much attention.
Oura is reportedly preparing to raise as much as $3 billion through a US IPO, with a potential valuation above $16 billion. Whoop, meanwhile, has already raised hundreds of millions of dollars at a $10 billion valuation and is preparing for an IPO of its own.
The excitement is not simply about smart rings or fitness bands. The bigger investment story is about whether these companies can turn personal biometric data into a sticky software business.
And that is where things get particularly interesting.
The Wearable Is Only the Beginning
The easiest way to misunderstand Oura and Whoop is to think of them as hardware companies.
The hardware gets the customer through the door, but the subscription is what keeps the relationship going.
Oura sells its smart ring as a physical product, with its latest ring priced at $399, and charges $5.99 a month for membership. Whoop has taken the subscription model even further. Its hardware is essentially part of the membership experience, with plans starting at $199 a year.
That difference matters.
A traditional consumer electronics company needs to persuade customers to buy another device every few years. A subscription business has a different economic engine. Once a customer is paying every month or every year, the company has a continuing opportunity to generate revenue from that relationship.
The device becomes the entry point. The software becomes the business.
This is also why user retention is so important.
If people stop wearing their Oura ring or Whoop band after a few months, the entire model becomes much less attractive. But if the device becomes part of someone’s daily routine, the economics can look very different.
And these products are unusually well positioned to become habits.
People check their sleep scores when they wake up. They look at recovery before training. They monitor their heart rate, activity, strain, readiness, and other metrics throughout the day.
The more consistently someone uses the device, the more useful the accumulated data can become.
That creates a powerful feedback loop.
Why AI Could Make These Products Harder to Leave
There is a major problem with health data.
Most people do not actually know what to do with it.
Knowing your resting heart rate is one thing. Knowing whether today’s number should change your workout, bedtime, diet, or recovery strategy is another.
This is where artificial intelligence could transform the wearable business.
Instead of simply showing users dozens of measurements, an AI-powered system can start interpreting those measurements in context.
Imagine the difference between:
“Your sleep score was 74.”
and:
“Your sleep has been inconsistent this week. Going to bed 45 minutes earlier tonight could improve your recovery tomorrow.”
The second one is much more useful.
It turns data into advice.
That is already the direction in which companies such as Whoop and Oura are moving. The more data they collect about an individual, the more personalized their recommendations can potentially become.
Your device does not just know that you slept for seven hours.
Over time, it can learn how your body responds to seven hours of sleep.
It can learn how late nights affect your training.
It can identify patterns between exercise and recovery.
It can recognize that certain habits repeatedly coincide with better or worse sleep.
That accumulated context is potentially one of the most valuable assets these companies possess.
Whoop’s Appeal Goes Beyond Fitness
Whoop has increasingly expanded the conversation from exercise performance into broader health and longevity.
One example is Whoop Age, which estimates a user’s physiological age based on health data. The company also offers a metric called Pace of Aging, designed to show whether someone’s habits are associated with a slower or faster rate of physiological aging.
Whether consumers ultimately treat these metrics as meaningful health indicators is another question. But from a business perspective, the psychology is powerful.
People are naturally interested in knowing whether their lifestyle is helping or hurting them.
A simple question such as “Am I aging well?” is much more emotionally compelling than a dashboard filled with disconnected statistics.
That makes the product feel personal.
It also gives customers a reason to keep coming back.
The Finance Crowd Gets It
There is another reason Oura and Whoop have generated so much enthusiasm.
Their products have become surprisingly visible among wealthy professionals, executives, athletes, entrepreneurs, and people working in finance and technology.
That matters because products often spread through social circles before they become mainstream.
Someone sees a colleague wearing a Whoop.
Someone else notices an Oura ring at the gym.
A friend starts talking about recovery scores over dinner.
Suddenly, a health tracker becomes less like a gadget and more like part of a lifestyle.
The social signaling is real, but the utility is real too.
That combination is difficult to manufacture.
Oura and Whoop are not selling products that people simply display. They are selling products that can become part of a daily routine.
For an investor, that is much more interesting.
Oura’s IPO Could Be the Bigger Test
Oura’s reported IPO ambitions are particularly striking.
A potential valuation above $16 billion would represent a significant increase from its previous valuation. Bloomberg’s reporting suggests the company could seek to raise as much as $3 billion in the offering.
At that kind of valuation, investors will inevitably ask a straightforward question:
Can Oura really justify being valued like a major software company?
The answer will depend heavily on revenue growth, margins, subscriber numbers, retention, and the company’s ability to expand beyond its current customer base.
The comparison with software companies makes sense in one respect. Recurring subscription revenue can produce much more predictable cash flows than one-time hardware sales.
But Oura still has to manufacture and sell physical devices.
That means investors cannot simply treat it like a pure software company.
The real attraction is the combination of the two.
Hardware creates the relationship. Software monetizes the relationship. Data improves the software. AI potentially makes the software more valuable.
That is the investment thesis in a nutshell.
Whoop Has a Different Advantage
Whoop’s positioning is somewhat different.
The company has built a strong identity around athletes, training, recovery, and performance. Its screenless approach also distinguishes it from traditional smartwatches.
Instead of putting another bright screen on your wrist, Whoop is designed to collect information in the background and deliver insights through its app.
That is an interesting philosophy.
The company is essentially saying that the wearable should not demand your attention.
It should collect the information quietly and tell you what matters later.
Whoop also reportedly became cash-flow positive last year, an important milestone for a company approaching the public markets.
Its $575 million financing round in March at a $10 billion valuation gives investors a useful reference point for how private markets currently view the business.
The company’s expansion of its Boston headquarters also signals that management is preparing for the next stage of growth.
The Real Moat Is Not the Ring or the Band
This is probably the most important point for investors.
A competitor can eventually build a better sensor.
Apple, Samsung, Google, Garmin, Fitbit and other companies already operate in adjacent categories.
Hardware itself is rarely an unbeatable moat.
The harder thing to replicate is the combination of hardware, longitudinal data, software, user behavior, and trust.
Imagine wearing the same device for five years.
The company potentially has five years of information about your sleep, activity, workouts, recovery, heart rate patterns, routines, and behavioral changes.
A new competitor may be able to offer a technically impressive device on day one.
But it cannot instantly recreate five years of personal history.
That creates switching costs.
Not necessarily because the customer physically cannot switch, but because switching means leaving behind a personalized record that has accumulated over time.
The longer the relationship lasts, the more valuable that history could become.
But There Are Serious Risks
The bullish story has plenty of holes that investors should examine.
The biggest is data privacy.
These devices collect information that is extraordinarily personal. Sleep patterns, heart rate, exercise habits, reproductive health information, daily routines, and other biometric measurements are far more intimate than the data collected by many ordinary consumer products.
That creates a huge responsibility for the companies.
A major privacy scandal could damage consumer trust quickly.
There is also competition.
The largest technology companies in the world have enormous resources and existing relationships with hundreds of millions of consumers. Apple, Google, Samsung and others can invest aggressively in sensors, artificial intelligence, health platforms, and wearable devices.
Then there is the question of whether consumers will continue paying subscriptions.
People are increasingly surrounded by monthly charges for software, entertainment, cloud storage, fitness, news, and other services.
Eventually, some consumers will decide they have enough subscriptions.
Oura and Whoop need to make their services valuable enough that customers consider them essential rather than optional.
The Subscription Is the Key
That is why the recurring-revenue model matters so much.
If a customer buys a ring once and disappears, Oura has a hardware sale.
If that customer buys the ring and remains a subscriber for five years, the economics are completely different.
The same principle applies to Whoop.
The ultimate product is not the wearable. It is the continuing relationship with the customer.
And AI could strengthen that relationship.
If the software becomes noticeably better every year, users have a reason to stay.
If the recommendations become more personalized, the service becomes harder to replace.
If the company can connect today’s behavior with long-term outcomes, the value of the data grows.
That is why AI is not just a marketing feature for these companies.
It could become the mechanism that protects the subscription business.
Could Oura and Whoop Become Healthcare Companies?
This is where the long-term opportunity becomes much larger.
Today, most consumers use these devices for fitness, sleep, recovery, and lifestyle optimization.
But the same biometric information could eventually become useful in healthcare.
The healthcare industry is increasingly interested in continuous data rather than occasional snapshots.
A doctor sees a patient for a few minutes.
A wearable can potentially collect information around the clock.
That does not mean consumer wearables will replace doctors. They will not.
But the possibility of integrating wearable data into healthcare creates an enormous potential market.
The companies that successfully build the bridge between consumer health and clinical healthcare could eventually be worth far more than companies selling fitness accessories.
There is still a long road between today’s products and that future.
Regulation, accuracy, privacy, clinical validation, and interoperability all matter.
But investors are likely to think about that opportunity when they value these companies.
Why Investors Are Paying Attention Now
The broader market environment also helps explain the excitement.
Investors have spent years looking for businesses that can benefit from artificial intelligence.
Semiconductor companies have been among the biggest beneficiaries of the AI boom because they provide the infrastructure required to run increasingly powerful models.
Biotech is attracting attention because AI could potentially accelerate drug discovery and reduce research costs.
Wearables represent another part of the same story.
Instead of using AI to discover a drug, the idea is to use AI to make sense of the enormous amount of health data generated by individuals.
The next AI opportunity may not always be the company building the model. It may be the company sitting on the data and owning the customer relationship.
That is a much more interesting way to look at Oura and Whoop.
The IPO Will Test the Entire Thesis
Public investors will ultimately be less interested in the excitement surrounding the products and more interested in the numbers.
They will want to know:
- How quickly is revenue growing?
- How many subscribers are paying?
- What percentage renews each year?
- How much does it cost to acquire a customer?
- How profitable is each subscriber over time?
- What are the hardware margins?
- How quickly can software revenue grow?
- Can AI materially improve retention?
- How defensible is the company’s data advantage?
- What happens when Apple and other technology giants compete more aggressively?
Those questions will determine whether the IPO valuations look visionary or excessive.
A $16 billion valuation sounds enormous.
But valuation is ultimately a function of what investors believe a company can become.
If Oura becomes a global consumer health platform with high subscription retention, strong software margins, and meaningful healthcare applications, today’s valuation could eventually look reasonable.
If it remains primarily a premium smart ring with a subscription attached, the market may reach a very different conclusion.
The same applies to Whoop.
The Bigger Bet
The most compelling part of the Oura and Whoop story is not that people like wearing their products.
It is that the companies are building something that becomes more useful as the customer continues using it.
That is a powerful business model.
Every morning, the customer generates new data.
Every workout creates another data point.
Every night adds another sleep record.
Every month gives the software more information about the person.
And increasingly, AI can help turn all of that information into recommendations that feel personal.
That creates a cycle of data, insight, behavior, and more data.
The longer it continues, the harder the product may become to abandon.
That is what investors are really buying into.
Not a ring.
Not a wristband.
Not even a fitness subscription.
They are buying into the possibility that personal health data becomes one of the most valuable consumer software categories of the next decade.
Oura and Whoop are trying to establish themselves at the center of that market before it fully arrives.
Their IPOs will tell us whether public investors believe the opportunity is as large as the private markets currently suggest.
For now, the thesis is compelling.
The wearable is the hardware. The subscription is the business. The data is the asset. And AI may be the glue that holds the whole thing together.
That is why Oura and Whoop could be much more than the next hot consumer-tech IPOs.
They could be early bets on what personal healthcare looks like in the AI era.